Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The described entity is a mechanism rather than a discrete molecular target: it refers to the **antibacterial effect exerted by the release of copper ions (primarily from a Cu₂O—cuprous oxide—shell or nanoparticles)**. When released from such nanomaterials, **copper ions can physically and chemically damage bacterial cell walls and cytoplasmic membranes**, frequently by generating **reactive oxygen species (ROS)** or by direct disruption of membrane integrity. Some studies highlight the unique role of defect sites or specific crystalline faces (such as Vo-(111)Cu₂O) in enhancing ROS generation and localized copper ion release, leading to superior bactericidal activity[1][7][5]. The process does not target a single defined receptor or molecular entity, but rather indiscriminately affects multiple components of bacterial structure, including the cell wall and internal constituents, leading to bacterial death. This broad mechanism underpins the use of copper-containing nanomaterials as antimicrobial agents and has been investigated in the context of wound healing and design of antibacterial coatings[5][4][7]. **Note:** This is **not a conventional drug target or molecular receptor** (such as an enzyme, transporter, or canonical cell wall protein like peptidoglycan synthase)[6], but rather a generalized mechanism involving multiple physical and chemical effects on bacteria[7][1]. Therefore, it should not be considered a \"therapeutic target\" in the strategic sense used in pharmacology or chemical biology.
Release of copper ions causing oxidative damage to bacterial cell membranes and internal components[7][1][4] - Generation of reactive oxygen species (ROS) leading to oxidative stress and cell death[1][4][5] - Physical disruption of the bacterial cell wall and cytoplasmic membrane through contact action[1][7][8] - Synergistic effects when combined with other metals (e.g., silver) via cooperative ROS production and enhanced ion release[2][4]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper-induced bacterial cell wall and cytoplasmic damage.